(AGENPARL) - Roma, 16 Marzo 2023(AGENPARL) – SILVER SPRING gio 16 marzo 2023 FDA launched the FDA Rare Neurodegenerative Disease Grant Program when the Accelerating Access to Critical Therapies for ALS was enacted.
Fonte/Source: http://www.fda.gov/industry/medical-products-rare-diseases-and-conditions/rare-neurodegenerative-disease-grant-program